INT126555

From wiki-pain
Jump to: navigation, search
Context Info
Confidence 0.35
First Reported 2005
Last Reported 2005
Negated 0
Speculated 0
Reported most in Abstract
Documents 1
Total Number 2
Disease Relevance 2.20
Pain Relevance 0.80

This is a graph with borders and nodes. Maybe there is an Imagemap used so the nodes may be linking to some Pages.

extracellular space (Ighg1, Tnf) cell proliferation (Tnf) signal transduction (Tnf)
extracellular region (Tnf) plasma membrane (Tnf) intracellular (Tnf)
Ighg1 (Mus musculus)
Tnf (Mus musculus)
Pain Link Frequency Relevance Heat
Infliximab 8 99.76 Very High Very High Very High
rheumatoid arthritis 2 96.72 Very High Very High Very High
Arthritis 2 91.68 High High
Neuritis 4 75.00 Quite High
Disease Link Frequency Relevance Heat
Necrosis 2 100.00 Very High Very High Very High
Cancer 2 100.00 Very High Very High Very High
Crohn's Disease 2 97.92 Very High Very High Very High
Rheumatoid Arthritis 2 96.72 Very High Very High Very High
Juvenile Chronic Polyarthritis 2 93.28 High High
Disease 2 90.08 High High
Uveitis 4 85.76 High High
Infection 2 78.16 Quite High
Optic Neuritis 4 75.00 Quite High
Lymphatic System Cancer 2 71.76 Quite High

Sentences Mentioned In

Key: Protein Mutation Event Anatomy Negation Speculation Pain term Disease term
Infliximab is a chimeric human-murine monoclonal antibody of the IgG1 type with a high affinity and specificity for tumor necrosis factor alpha (TNFalpha).
IgG1 Binding (affinity) of tumor necrosis factor associated with necrosis, infliximab and cancer
1) Confidence 0.35 Published 2005 Journal J Fr Ophtalmol Section Abstract Doc Link 15851955 Disease Relevance 1.09 Pain Relevance 0.40
Infliximab is a chimeric human-murine monoclonal antibody of the IgG1 type with a high affinity and specificity for tumor necrosis factor alpha (TNFalpha).
IgG1 Binding (affinity) of TNFalpha associated with necrosis, infliximab and cancer
2) Confidence 0.35 Published 2005 Journal J Fr Ophtalmol Section Abstract Doc Link 15851955 Disease Relevance 1.10 Pain Relevance 0.40

General Comments

This test has worked.

Personal tools
Namespaces

Variants
Actions
Navigation
Toolbox